论文部分内容阅读
目的:分析对慢性肺源性心脏病急性发作期患者采取中西医结合治疗的临床效果。方法:选择沁阳市人民医院2015年2月至2016年7月收治的112例慢性肺源性心脏病急性发作期患者,按照床位单双号顺序分为两组,其中56例患者采取西医常规治疗方案作为对照组,另56例患者则在西医治疗基础上联合中医治疗作为研究组,比较两组患者的临床效果。结果:经过观察两组患者治疗前后相关指标看出,治疗前两组患者各项指标比较,差异均无统计学意义(P>0.05),治疗后研究组患者血氧分压(Pa O2)(76.6±6.2)mm Hg和心脏射血分数(51.3±4.1)%均高于对照组(74.2±5.8)mm Hg、(44.2±3.7)%,研究组血二氧化碳分压(Pa CO2)(43.1±3.6)mm Hg低于对照组(57.4±4.4)mm Hg,且研究组不良反应发生率为10.71%,对照组不良反应发生率为21.43%,差异均具有统计学意义(P<0.05)。结论:治疗慢性肺源性心脏病急性发作期患者采取中西医联合方式,治疗后患者各项指标恢复正常,临床效果更好,安全性更高。
Objective: To analyze the clinical effect of combined traditional Chinese and western medicine on patients with acute episode of chronic cor pulmonale. Methods: One hundred and twelve patients with acute exacerbation of chronic cor pulmonale who were treated in Qinyang People’s Hospital from February 2015 to July 2016 were divided into two groups according to the order of single and double beds. Fifty-six of the 56 patients took conventional Western medicine Treatment regimen as a control group, and the other 56 patients on the basis of Western medicine combined with Chinese medicine as a research group, comparing the clinical effect of two groups of patients. Results: After observing the related indexes of two groups before and after treatment, there was no significant difference between the two groups before treatment (P> 0.05). After treatment, the PaO2 ( 76.2 ± 6.2) mmHg, and heart ejection fraction (51.3 ± 4.1)% were significantly higher than those in the control group (74.2 ± 5.8 mmHg, 44.2 ± 3.7%). The study group had a PaCO 2 pressure of 43.1 ± 3.6) mm Hg was lower than that of the control group (57.4 ± 4.4) mm Hg, and the adverse reaction rate was 10.71% in the study group and 21.43% in the control group. The difference was statistically significant (P <0.05). Conclusion: The treatment of chronic cor pulmonale patients with acute exacerbation of Chinese and Western medicine combined with the treatment of patients with various indicators returned to normal, the clinical effect is better and more secure.